Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1980 1
1981 1
1984 1
1986 1
1987 1
1988 1
1989 4
1990 3
1991 1
1992 3
1993 7
1994 3
1995 6
1996 5
1997 2
1998 1
1999 4
2000 3
2001 3
2002 3
2003 5
2004 5
2005 7
2006 6
2007 4
2009 5
2010 3
2011 2
2012 4
2013 5
2014 3
2015 6
2016 7
2017 3
2018 3
2019 2
2020 4
2021 9
2022 4
2023 4
2024 5
2025 8
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Comparison of cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis.
Yazdani N, Sadeghi R, Momeni-Moghaddam H, Zarifmahmoudi L, Ehsaei A. Yazdani N, et al. J Optom. 2018 Jul-Sep;11(3):135-143. doi: 10.1016/j.optom.2017.09.001. Epub 2017 Nov 11. J Optom. 2018. PMID: 29132914 Free PMC article.
PURPOSE: The aim of the present meta-analysis is to compare the efficacy of cyclopentolate and tropicamide in controlling accommodation during refraction. METHODS: A comprehensive literature search was performed in PubMed, Scopus, Science direct and Ovid databases by the k …
PURPOSE: The aim of the present meta-analysis is to compare the efficacy of cyclopentolate and tropicamide in controlling accommodati …
Comparative efficacy of tropicamide 1% and cyclopentolate 1% for cycloplegic refraction: A systematic review and meta-analysis of randomized controlled trials.
Bist J, Paudel N, Kandel S, Marasini S. Bist J, et al. Optom Vis Sci. 2025 Mar 1;102(3):175-180. doi: 10.1097/OPX.0000000000002226. Epub 2025 Feb 13. Optom Vis Sci. 2025. PMID: 39937702
BACKGROUND: Cyclopentolate 1% is considered the drug of choice for effective cycloplegic refraction in clinical population, although tropicamide 1% is also reported to have similar effects with better tolerability. OBJECTIVES: The objective of this meta-analysis was to eva …
BACKGROUND: Cyclopentolate 1% is considered the drug of choice for effective cycloplegic refraction in clinical population, although trop …
Tropicamide Versus Cyclopentolate for Cycloplegic Refraction in Pediatric Patients With Brown Irides: A Randomized Clinical Trial.
Al-Thawabieh W, Al-Omari R, Abu-Hassan DW, Abuawwad MT, Al-Awadhi A, Abu Serhan H. Al-Thawabieh W, et al. Am J Ophthalmol. 2024 Jan;257:218-226. doi: 10.1016/j.ajo.2023.09.022. Epub 2023 Oct 4. Am J Ophthalmol. 2024. PMID: 37797867 Free article. Clinical Trial.

The SE after instillation of cyclopentolate and tropicamide in both eyes was 1.075.2 and 0.965.1, respectively (P value < .001). The average deltaSE after cycloplegia was 1.151.2 for cyclopentolate and 1.041.2 for tropicamide (P value < .001). ...The greatest

…

The SE after instillation of cyclopentolate and tropicamide in both eyes was 1.075.2 and 0.965.1, respectively (P value < .001). T

…
Effects of tropicamide and compound tropicamide eye drops on ocular biological parameters and choroid thickness in children.
Xu M, Li N, Liu Y, Chen Y, Xie S, Wang J. Xu M, et al. BMC Ophthalmol. 2025 Jan 20;25(1):31. doi: 10.1186/s12886-025-03872-9. BMC Ophthalmol. 2025. PMID: 39833766 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate the effects of short-acting cycloplegic agents, tropicamide and compound tropicamide, on ocular biological parameters and choroid thickness. ...CONCLUSIONS: Some ocular biological parameters were altered after application of short-acting cycl …
OBJECTIVES: To evaluate the effects of short-acting cycloplegic agents, tropicamide and compound tropicamide, on ocular biolog …
Short-term effects of cyclopentolate and tropicamide eye drops on macular choroidal thickness in myopic children.
Kobia-Acquah E, Flitcroft DI, Lingham G, Kerin E, Loughman J. Kobia-Acquah E, et al. Ophthalmic Physiol Opt. 2024 Mar;44(2):280-291. doi: 10.1111/opo.13256. Epub 2023 Nov 30. Ophthalmic Physiol Opt. 2024. PMID: 38037443 Clinical Trial.
BACKGROUND: To investigate the short-term effects of cyclopentolate and tropicamide eyedrops on choroidal thickness (ChT) in myopic children using placebo or low-dose atropine eyedrops. ...RESULTS: Mean changes in subfoveal ChT after two drops of tropicamide and one …
BACKGROUND: To investigate the short-term effects of cyclopentolate and tropicamide eyedrops on choroidal thickness (ChT) in myopic c …
Interventions to slow progression of myopia in children.
Walline JJ, Lindsley KB, Vedula SS, Cotter SA, Mutti DO, Ng SM, Twelker JD. Walline JJ, et al. Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD004916. doi: 10.1002/14651858.CD004916.pub4. Cochrane Database Syst Rev. 2020. PMID: 31930781 Free PMC article.
Another study showed favorable results for three different doses of atropine eye drops compared with tropicamide eye drops (MD 0.78 D, 95% CI 0.49 to 1.07 for 0.1% atropine; MD 0.81 D, 95% CI 0.57 to 1.05 for 0.25% atropine; and MD 1.01 D, 95% CI 0.74 to 1.28 for 0.5% atro …
Another study showed favorable results for three different doses of atropine eye drops compared with tropicamide eye drops (MD 0.78 D …
Mydriasis with micro-array print touch-free tropicamide-phenylephrine fixed combination MIST: pooled randomized Phase III trials.
Wirta DL, Walters TR, Flynn WJ, Rathi S, Ianchulev T. Wirta DL, et al. Ther Deliv. 2021 Mar;12(3):201-214. doi: 10.4155/tde-2021-0011. Epub 2021 Mar 15. Ther Deliv. 2021. PMID: 33715382 Free article. Clinical Trial.
MIST-1 study subjects received fixed-combination TR-PH, phenylephrine 2.5% (PH) or tropicamide 1% (TR). MIST-2 study subjects received TR-PH or placebo. Mean change from baseline in pupil diameter was measured by digital pupillometry at 35 min postadministration. ...
MIST-1 study subjects received fixed-combination TR-PH, phenylephrine 2.5% (PH) or tropicamide 1% (TR). MIST-2 study subjects receive …
Evaluation of efficacy of intracameral lidocaine and tropicamide injection in manual small-incision cataract surgery: A prospective clinical study.
Bhat KT, Wadgaonkar SP, Undre AA, Heda AS. Bhat KT, et al. Indian J Ophthalmol. 2022 Nov;70(11):3849-3852. doi: 10.4103/ijo.IJO_2050_22. Indian J Ophthalmol. 2022. PMID: 36308110 Free PMC article. Clinical Trial.
PURPOSE: The study was conducted to evaluate efficacy of intracameral lidocaine hydrochloride 1% and tropicamide injection 0.02% for anaesthesia and mydriasis in manual small-incision cataract surgery (MSICS) and to report any adverse drug reaction. ...Fixed dose combinati …
PURPOSE: The study was conducted to evaluate efficacy of intracameral lidocaine hydrochloride 1% and tropicamide injection 0.02% for …
Tropicamide (1%): an effective cycloplegic agent for myopic children.
Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K; COMET Study Group. Manny RE, et al. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. Invest Ophthalmol Vis Sci. 2001. PMID: 11431435 Clinical Trial.
PURPOSE: To evaluate the cycloplegic effect of 1% tropicamide in myopic children and to determine whether its efficacy is associated with age, gender, iris color, ethnicity, magnitude of the refractive error, or latent error. ...Small but statistically significant differen …
PURPOSE: To evaluate the cycloplegic effect of 1% tropicamide in myopic children and to determine whether its efficacy is associated …
The effects of tropicamide and cyclopentolate hydrochloride on laser flare meter measurements in uveitis patients: a comparative study.
Yilmaz M, Guven Yilmaz S, Palamar M, Ates H, Yagci A. Yilmaz M, et al. Int Ophthalmol. 2021 Mar;41(3):853-857. doi: 10.1007/s10792-020-01639-3. Epub 2020 Nov 16. Int Ophthalmol. 2021. PMID: 33200390 Clinical Trial.
PURPOSE: To investigate the effects of 1% cyclopentolate hydrochloride and 1% tropicamide eye drops on aqueous flare measurements by using the laser flare meter. METHODS: One hundred forty eight eyes of 83 patients with inactive uveitis were enrolled. The patients were ran …
PURPOSE: To investigate the effects of 1% cyclopentolate hydrochloride and 1% tropicamide eye drops on aqueous flare measurements by …
143 results